Key Highlights: Primary Endpoint Met: Orforglipron achieved superior A1C reduction vs placebo at 40 weeks: A1C reduction: 1.3% to 1.6% vs 0.1% for placebo Over 65% of patients on highest dose reached A1C 6.5% Promising Weight Loss: Patients on the highest dose experienced an average weight loss of 7.9%, with Lilly noting the effect hadnt yet plateaued
For a general overview of IV vitamin therapy, Healthline provides a comprehensive review of benefits and precautions
At our clinic, find out if this cutting-edge treatment is right for you
It got to the point where I had to pack a bag with a change of clothes so if I got sick at work, I could change clothes.' Kelly's suit alleges she suffered 'severe and permanent personal injuries, pain, suffering, and emotional distress, and incurred medical expenses'
Potential anti-tumor effects of pomegranates and its ingredients
Consider substitutes like cauliflower, corn, and other plant based products instead of pastas and white rice